公开(公告)号：WO2002081481A1

公开(公告)日：2002-10-17

申请号：PCT/US2002/006664

申请日：2002-03-27

Applicant: ELI LILLY AND COMPANY ,  LANDER, Peter, Ambrose ,  LOHMAN, Mark, Christopher

Inventor： LANDER, Peter, Ambrose ,  LOHMAN, Mark, Christopher

IPC: C07D498/14

CPC classification number: C07D498/04

Abstract: The present invention relates to a compound of formula (I) which are useful for inhibiting resistant neoplasms where the resistance is conferred in part or in total by MRP1.

Abstract translation: 本发明涉及式（I）化合物，其可用于抑制MRP1部分或全部赋予抗性的抗性赘生物。

公开(公告)号：WO0127116A3

公开(公告)日：2001-11-22

申请号：PCT/US0021980

申请日：2000-09-22

Applicant: LILLY CO ELI ,  BONJOUKLIAN ROSANNE ,  JOHNSON DOUGLAS WEBB ,  LANDER PETER AMBROSE ,  LOHMAN MARK CHRISTOPHER ,  PATEL VINOD FRANCIS ,  VEPACHEDU SREENIVASARAO ,  XIE YONGPING

Inventor： BONJOUKLIAN ROSANNE ,  JOHNSON DOUGLAS WEBB ,  LANDER PETER AMBROSE ,  LOHMAN MARK CHRISTOPHER ,  PATEL VINOD FRANCIS ,  VEPACHEDU SREENIVASARAO ,  XIE YONGPING

IPC: A61P35/00 ,  C07D471/04 ,  C07D498/04 ,  A61K31/4741 ,  A61K31/4745

CPC classification number: C07D471/04

Abstract: The present invention relates to a compound of formula (I), which are useful for inhibiting resistant neoplasms where the resistance is conferred in part or in total by MRP1.

Abstract translation: 本发明涉及式（I）化合物，其可用于抑制MRP1部分或全部赋予抗性的抗性肿瘤。